The joint venture CRO is based in Bangkok and is expected to conduct clinical research in key South East Asian countries under the name Ecron Acunova Company (EACL) and will be led by Eugene Kroon as the CEO of EACL.
Ecron Acunova founder and chairman D A Prasanna said that as sponsors increasingly include Southeast Asia in drug development programmes it is imperative for them to establish their operations in collaboration with regional experts like Chulalongkorn University.
EACL CEO Eugene Kroon said that Ecron Acunova’s Center of Excellence to conduct nutritional studies and studies in HIV will be setup at Bangkok.
"EACL currently offers services in Thailand, Malaysia, Vietnam and Cambodia and intends to expand its operation to other key countries in SEA," Kroon said.